• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型隐球菌临床分离株体外药敏试验的比浊法和视觉标准。

Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates.

作者信息

Del Poeta M, Barchiesi F, Arzeni D, Marinucci G, Scalise G

机构信息

Institute of Infectious Diseases and Public Health, University of Ancona, Italy.

出版信息

Mycoses. 1994 Nov-Dec;37(11-12):411-6. doi: 10.1111/j.1439-0507.1994.tb00391.x.

DOI:10.1111/j.1439-0507.1994.tb00391.x
PMID:7659128
Abstract

The drug concentration which inhibited 50% of growth (IC50), the lowest drug concentration at which growth was less than 30% of that in a positive control well (IC30), the visual minimal inhibitory concentration (MIC visual), were applied to study the effects of fluconazole, itraconazole, amphotericin B and flucytosine against 27 isolates of Cryptococcus neoformans by a broth microdilution technique. When the recommendations established by NCCLS Subcommittee on Antifungal Susceptibility Test were applied for the visual reading of the microplates, the results were comparable with those obtained by the turbidimetric method. No statistically significant differences between MIC visual and IC30 readings were observed with the azoles. There were, however, differences with amphotericin B and flucytosine. In absolute terms MICs of amphotericin B and flucytosine showed higher values than IC30s and IC50s.

摘要

采用肉汤微量稀释技术,应用抑制50%生长的药物浓度(IC50)、生长低于阳性对照孔30%时的最低药物浓度(IC30)、可视最小抑菌浓度(MIC可视),研究氟康唑、伊曲康唑、两性霉素B和氟胞嘧啶对27株新型隐球菌的作用。当按照美国国家临床实验室标准委员会抗真菌药敏试验小组委员会制定的建议对微孔板进行可视读数时,结果与比浊法获得的结果相当。对于唑类药物,MIC可视读数和IC30读数之间未观察到统计学上的显著差异。然而,两性霉素B和氟胞嘧啶存在差异。从绝对值来看,两性霉素B和氟胞嘧啶的MIC值高于IC30和IC50值。

相似文献

1
Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates.新型隐球菌临床分离株体外药敏试验的比浊法和视觉标准。
Mycoses. 1994 Nov-Dec;37(11-12):411-6. doi: 10.1111/j.1439-0507.1994.tb00391.x.
2
Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans.用于确定六种抗真菌药物对念珠菌属和新型隐球菌体外活性的比浊法和目视标准。
Mycopathologia. 1993 Oct;124(1):19-25. doi: 10.1007/BF01103052.
3
Susceptibility testing of Cryptococcus neoformans: a microdilution technique.新型隐球菌药敏试验:一种微量稀释技术。
J Clin Microbiol. 1992 Nov;30(11):2881-6. doi: 10.1128/jcm.30.11.2881-2886.1992.
4
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.在体外对从塞尔维亚患者脑脊液和血液中分离的新型隐球菌的两性霉素 B、5-氟胞嘧啶、氟康唑和伊曲康唑的抗真菌活性。
J Mycol Med. 2012 Sep;22(3):243-8. doi: 10.1016/j.mycmed.2012.06.002. Epub 2012 Aug 10.
5
In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method.使用比色系统和参考微量肉汤法检测新型隐球菌分离株对五种抗真菌药物的体外敏感性。
J Antimicrob Chemother. 2000 May;45(5):645-9. doi: 10.1093/jac/45.5.645.
6
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.采用各种抗真菌药敏试验方法所获得的结果并不能预测隐球菌病患者的早期临床结局。
Antimicrob Agents Chemother. 2006 Jul;50(7):2464-70. doi: 10.1128/AAC.01520-05.
7
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.念珠菌属和新型隐球菌抗真菌药敏试验的Etest法多中心评估。英国抗菌化疗学会工作组
J Antimicrob Chemother. 1998 Sep;42(3):321-31. doi: 10.1093/jac/42.3.321.
8
Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.来自HIV感染和未感染患者的新型隐球菌和格特隐球菌分离株:抗真菌药敏性及隐球菌病的转归
Rev Inst Med Trop Sao Paulo. 2017;59:e49. doi: 10.1590/S1678-9946201759049. Epub 2017 Aug 3.
9
Antifungal susceptibilities of Cryptococcus species complex isolates from AIDS and non-AIDS patients in Southeast China.中国东南部 AIDS 及非 AIDS 患者感染隐球菌属种复合体的抗真菌药敏试验结果。
Braz J Infect Dis. 2012 Mar-Apr;16(2):175-9. doi: 10.1016/s1413-8670(12)70301-x.
10
Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.新型隐球菌对四种抗真菌药物的抗真菌药敏试验中Etest法与微量稀释法的比较。
J Antimicrob Chemother. 2000 Dec;46(6):997-1000. doi: 10.1093/jac/46.6.997.

引用本文的文献

1
Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods.使用不同终点标准和培养时间对丝状真菌进行最低抑菌浓度(MIC)测定的三种方法的比较。
Antimicrob Agents Chemother. 2000 Feb;44(2):239-42. doi: 10.1128/AAC.44.2.239-242.2000.
2
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies.新型隐球菌临床分离株中两性霉素B耐药性的检测:采用E-test和美国国家临床实验室标准委员会M27-A方法评估三种不同培养基的性能
J Clin Microbiol. 1998 Oct;36(10):2817-22. doi: 10.1128/JCM.36.10.2817-2822.1998.